title: Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
authors.affiliation: University of Texas Health Science Center, San Antonio.
authors.forename: T D
authors.initials: TD
authors.lastname: Brown
authors.forename: P J
authors.initials: PJ
authors.lastname: Goodman
authors.forename: T R
authors.initials: TR
authors.lastname: Fleming
authors.forename: L H
authors.initials: LH
authors.lastname: Baker
authors.forename: J S
authors.initials: JS
authors.lastname: Macdonald
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D017290:Menogaril; D008875:Middle Aged; D009621:Nogalamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D017290:Menogaril; D009621:Nogalamycin